BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

931 related articles for article (PubMed ID: 16723862)

  • 1. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?
    Struijker-Boudier HA; Ambrosioni E; Holzgreve H; Laurent S; Mancia G; Ruilope LM; Waeber B
    Int J Clin Pract; 2007 Sep; 61(9):1592-602. PubMed ID: 17686100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADVANCE: breaking new ground in type 2 diabetes.
    Chalmers J; Perkovic V; Joshi R; Patel A
    J Hypertens Suppl; 2006 Aug; 24(5):S22-8. PubMed ID: 16936533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
    Waeber B; de la Sierra A; Ruilope LM
    Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ADVANCE study: objectives, design and current status].
    Chalmers J
    Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected].
    Ghiadoni L
    Expert Opin Pharmacother; 2010 Jul; 11(10):1647-57. PubMed ID: 20518617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of therapeutic strategies in the management of hypertension].
    Waeber B
    Curr Med Res Opin; 2005; 21 Suppl 5():S13-6. PubMed ID: 16197647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perindopril + indapamide: new preparation. Simple trick.
    Prescrire Int; 1999 Dec; 8(44):172-5. PubMed ID: 11503814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
    Laurent S
    J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the ADVANCE study for clinical practice.
    Zannad F
    J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
    Ruilope LM; Segura J
    J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension: which aspects of hypertension should we impact on and how?
    Zanchetti A; Waeber B
    J Hypertens Suppl; 2006 Aug; 24(5):S2-5. PubMed ID: 16936532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
    Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
    J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration.
    Joannides R; Bellien J; Thurlure C; Iacob M; Abeel M; Thuillez C
    Am J Hypertens; 2008 Jun; 21(6):679-84. PubMed ID: 18443573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
    Mourad JJ; Le Jeune S
    Curr Med Res Opin; 2009 Sep; 25(9):2271-80. PubMed ID: 19627177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADVANCE: action in diabetes and vascular disease.
    Patel A; Chalmers J; Poulter N
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S27-32. PubMed ID: 16075030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.